Nestlé Recalls Alfamino Infant Formula: A Precautionary Measure
In a recent development, Nestlé has taken a proactive approach to ensure the well-being of infants by recalling specific batches of its Alfamino infant formula in Australia. This decision comes as a precautionary measure due to the potential presence of cereulide, a toxin produced by certain strains of Bacillus cereus, which can cause nausea and vomiting.
The affected batches, manufactured in Switzerland, are as follows:
Product, Use-by Date, Batch Number
ALFAMINO, 17.04.2027, 51070017Y2
ALFAMINO, 18.04.2027, 51080017Y1
ALFAMINO, 28.05.2027, 51480017Y3
ALFAMINO, 29.05.2027, 51490017Y1
ALFAMINO, 22.07.2027, 52030017Y1
These 400g tins have been distributed through pharmacies and hospitals in Australia and New Zealand. Nestlé emphasizes that this recall is a precautionary step, adhering to their stringent product quality and safety standards.
Nestlé's Health Science General Manager, Michael Edde, expressed the company's commitment to infant safety, stating, 'The safety of infants is our utmost priority, and we apologize for any concern this may cause. This recall is a necessary measure to uphold our product quality and safety protocols.'
Parents are advised to seek medical advice if they have any concerns. It's important to note that no other batches or products of Alfamino are affected by this recall.
Food Standards Australia New Zealand (FSANZ) has issued instructions for consumers, urging them not to consume the affected products and to return them to the place of purchase for a full refund. As of now, no illnesses have been confirmed in connection with the recalled products.
This proactive approach by Nestlé highlights their dedication to maintaining the highest standards of product safety, even in the face of potential risks.
